Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

AquaVita NextGen vs Ivy Rx

AquaVita NextGen
Graded #415

Lower grade

vs+10.5
Ivy Rx
Graded #178

Higher grade

The verdict

Ivy Rx takes it — 66.8/100 to 56.3/100.

Ivy Rx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Telehealth provider offering tiered compounded semaglutide and tirzepatide programs.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueIvy Rx +39
23
62
Dose & formulationAquaVita NextGen +11
75
64
Clinical oversightEven
82
82
Labs & monitoringEven
53
53
FulfillmentIvy Rx +19
62
81
Contract termsIvy Rx +8
47
55
AquaVita NextGen · left barIvy Rx · right bar

The numbers

MetricAquaVita NextGenIvy Rx
WeighScore56.3/10066.8/100
GradeCC
Scorecard rank#415#178
Semaglutide$375/mo (first-month rate, compounded)$175/mo (starting dose, compounded)
Tirzepatide$320/mo (starting dose, 3-month plan, compounded)$275/mo (starting dose, compounded)
Coverage5 statesAll 50 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualYesInjection only
AquaVita NextGen

Graded #415 · C

Strengths

  • Physical address in Lake Forest CA
  • Named medical director (Dr. Steve Groke)
  • Both semaglutide and tirzepatide including ODT tablets
  • Compounding disclaimer present on site

Where it loses points

  • Only 5 states (AZ, CA, FL, TX, NV)
  • No LegitScript or PCAB accreditation
  • Primarily a local medspa expanding into telehealth
  • Only a first-month semaglutide price ($375, originally $499) is published; ongoing monthly price and all tirzepatide pricing remain unpublished
Ivy Rx

Graded #178 · C

Strengths

  • Both semaglutide and tirzepatide available
  • Compounded GLP-1 access

Where it loses points

  • Limited public information on program details

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard